Yahoo Web Search

Search results

  1. Our multidisciplinary clinical and research team at the Johns Hopkins Medicine Lyme Disease Research Center conducts groundbreaking research to improve the understanding of Lyme disease and its varied manifestations. Our goal is to translate our pioneering research into improved patient care, education, and health outcomes.

  2. Aug 18, 2021 · According to the Center for Disease Control and Prevention (CDC), the number of vector-borne diseases reported to the National Notifiable Diseases Surveillance System (NNDSS) between 2004 and 2016 reached a total of 642,602 cases. Of these, tick-borne diseases (TBDs) accounted for 77% (491,671 cases) of reported cases with the total number of ...

    • Jason R. Bobe, Brandon L. Jutras, Elizabeth J. Horn, Monica E. Embers, Allison Bailey, Robert L. Mor...
    • 2021
  3. People also ask

  4. The first-line standard of care treatment for adults with Lyme disease is doxycycline, a tetracycline antibiotic. Other antibiotics that have activity against borrelia include the penicillin-like antibiotic, amoxicillin, and the second generation cephalosporin, Ceftin. The mainstay of treatment is with oral (pill) antibiotics, but intravenous ...

  5. John Aucott, M.D., an infectious diseases specialist and the founding Director/physician of the Johns Hopkins Lyme Disease Research Center, is a world authority on this “post-treatment Lyme disease” (PTLD), a condition he helped define. Its symptoms are persistent, and can include fatigue, pain, weakness, brain fog, and sleep disorders.

  6. Feb 9, 2022 · Lyme arthritis first was described in the United States in 1977 after a report of a cluster of children with arthritis living in Old Lyme, Connecticut.1 In the subsequent 45 years, Lyme disease has come to be recognized as an infectious disease that if left untreated may involve multiple organ systems, including the skin, joints, heart, and nervous system, and is referred to as Lyme ...

  7. Lyme disease is a major, global vector-borne disease, but research for improved prevention, diagnosis and treatment lags other diseases. Federal funding per new reported case of Lyme disease ($1,070) is a fraction of that for HIV/AIDS ($97,648) and hepatitis C ($47,522). Source: Tickborne Disease Working Group - US Department of Health and ...

  1. People also search for